Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideharu Ishida is active.

Publication


Featured researches published by Hideharu Ishida.


Vaccine | 1988

Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues

Ikuo Salki; Shinji Saito; Chiharu Fujita; Hideharu Ishida; Joji Iida; Jun Murata; Akira Hasegawa; Ichiro Azuma

The ability of various synthetic muramyl dipeptide (MDP) derivatives to induce the production of interleukin-1 (IL-1) and colony stimulating factor (CSF) in vitro and in vivo and to induce cytotoxic macrophages was studied. 6-O-L18-MDP(Me) and MDP-Lys(L18), which were potent inducers of IL-1 and CSF production and of cytotoxic macrophages, had protective activity against Sendai virus infection in mice. In contrast, 1-O-L18-(6-O-P)-MDP(Me) and 2-N-L18-MDP exhibited weak or no ability to induce IL-1 and CSF production and no induction of tumoricidal macrophages, and did not protect against infection of Sendai virus. MDP derivatives, except 2-N-L18-MDP, efficiently rendered macrophages cytotoxic against target cells in the presence of murine recombinant interferon-gamma in vitro. The derivatives that induced cytokines and cytotoxic macrophages appeared to produce anti-viral activity.


Journal of Carbohydrate Chemistry | 1986

Syntheses of Trehalose Monomycolate and Related Compounds, and Their Lethal Toxicity and Adjuvant Activity

Fumio Numata; Hideharu Ishida; Keiko Nishimura; Isao Sekikawa; Ichiro Azuma

Abstract Five monoesters, 6-O-mycoloyl-α, α-treha lose (TMM), 6-O-mycoloyl-D-glucose (GlcM), 6-O-mycoloyl-N-acetyl-D-glucosamine (GlcNAcM), 5-O-mycoloyl-D-arabinose (AraM) and 6-O-mycoloyl-D-galactose (GalM), were synthesized by use of mycolic acid isolated from Mycobacterium tuberculosis strain Aoyama B. Their toxicity and macrophage activating ability were examined in mice. A single intravenous administration of 400 μg of TMM in 9% oil-in-water emulsion killed 8 of 8 treated mice. The other analogs showed less lethal toxicity to mice at the same dose. Tumoricidal activity of mouse peritoneal macrophages was induced by intraperitoneal injection of TMM, GlcM, and GlcNAcM, respectively.


Carbohydrate Research | 1991

Chemical synthesis and biological activities of 6,6′-di-O-mycoloyl-β,β- and -α,β-trehalose

Ichiro Azuma; Takuma Sakurai; Hideharu Ishida; Toru Kitajima; Massayoshi Yamazaki

Abstract 6,6′-Di- O -mycoloyl-β,β-trehalose (β,β-TDM) and 6,6′-di- O -mycoloyl-α,β-trehalose (α,β-TDM) were synthesized and their toxicity and ability to activate peritoneal macrophages in situ were examined in mice, in comparison with 6,6′-di- O -mycoloyl-α,α-trehalose (TDM). Both β,β-TDM and α,β-TDM caused a decrease in body weight two days after injection, however the weights reverted to a normal level. No deaths were caused by either analog. On the other hand, TDM showed potent toxicity, causing decrease in body weight and death of all animals injected. β,β-TDM and α,β-TDM were effective in the in situ activation of mouse peritoneal macrophages.


Journal of Carbohydrate Chemistry | 1986

Chemical Combination of Biologically Active Derivatives ofN-Acetylmuramoyl Dipeptide and Lipid-A, and Their Biological Activities

Akira Hasegawa; Eiji Seki; Yushun Fujishima; Koji Kigawa; Makoto Kiso; Hideharu Ishida; Ichiro Azuma

Abstract Chemical coupling of biologically active derivatives of N-acetyl-muramoyl dipeptide with a derivative related to the nonreducing sub-unit of lipid A was carried out using acyl groups as a spacer. The products exhibited efficient antitumor activity, as well as strong, immunoadjuvant activity.


Archive | 1995

Glycolipid derivatives acting as ligands for selectins

Hideharu Ishida; Makoto Kiso; Akira Hasegawa


Vaccine | 1989

Lethal toxicity and adjuvant activities of synthetic TDM and its related compounds in mice

Takuma Sakurai; Ikuo Saiki; Hideharu Ishida; Koji Takeda; Ichiro Azuma


Carbohydrate Research | 1987

New synthetic immunomodulators combining a 4-O-phosphono-d-glucosamine derivative related to bacterial lipid A with 1-deoxy-N-acetylmuramoyl dipeptide analogs☆

Yushun Fujishima; Koji Kigawa; Yuji Ogawa; Makoto Kiso; Akira Hasegawa; Hideharu Ishida; Ichiro Azuma


Vaccine | 1988

Regression of line-10 hepatocellular carcinoma by a less toxic cord factor analogue combined with L18-MDP or synthetic lipid A analogues.

Hideharu Ishida; Ikuo Saiki; Shinji Saito; Akira Hasegawa; Makoto Kiso; Ichiro Azuma


Agricultural and biological chemistry | 1989

Synthesis and Immunoadjuvant Activity of the Conjugates of 1-Thio-N-acetyl-muramoyl Dipeptide with Lipid A Subunit Analogs

Yuji Ogawa; Masayuki Kitagawa; Yushun Fujishima; Makoto Kiso; Akira Hasegawa; Hideharu Ishida; Ichiro Azuma


Archive | 2004

Method of alpha-selective glycosylation

Hiromune Ando; Akihiro Imamura; Makoto Kiso; Hideharu Ishida

Collaboration


Dive into the Hideharu Ishida's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge